References
- Looi LM. Tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. Cancer 1987; 59: 466–70.
- Roitt I, Brostoff J, Male D. Cell migration and inflam-mation. In: Immunology. London: Mosby, 1993: 13.1-13.8.
- Koch AE, Burrow JC, Haines GK, Cals TM, Harlan JM, Leibovich SJ. Immunolocalization of endothelial and leukocyte adhesion molecules in human rheuma-toid and osteoarthritic synovial tissues. Lab Invest 1991; 64: 313–20.
- Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993; 91: 379–87.
- Birdsall HH, Lane C, Ramser MN, Anderson DC. Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adhe-sion. J Immunol 1992; 148: 2717–23.
- Banks RE, Gearing AJH, Hemingway IK, Norfolk DR, Perren TJ, Selby PJ. Circulating ICAM-1, E-se-lectin and VCAM-1 in human malignancies. Br J Can-cer 1993; 68: 122–4.
- Jong EC, Klebanoff SJ. Eosinophil-mediated mam-malian tumor cell cytotoxicity: role of the peroxidase system. J Immunol 1980; 124: 1949–53.
- Kita H, Adophson CR, Gleich GJ. Biology of eosinophilis. In: Middleton E, Reed CE, Ellis EF, et al., eds. Allergy: principles & practice, 5th edn., Vol. 1. St. Louis, MO: Mosby, 1998: 242–60.
- Sur S, Adolphson CR, Gleich GJ. Eosinophils: bio-chemical and cellular aspects. In: Middleton E, Reed CE, Ellis EF, et al., eds. Allergy: principles & practice, 4th edn., Vol. 1. St. Louis, MO: Mosby, 1993: 169–200.
- Her E, Frazer J, Austen KF, Owen WF. Eosinophll hematopoietins antagonize the programmed cell death of eosinophils, cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 1991; 88: 1982–7.
- Montefort S, Feather IH, Wilson SJ, et al. The expres-sion of leukocyte-endothelial adhesion molecules is in-creased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992; 7: 393–8.
- Gearing AJH, Newman W. Circulation adhesion molecules in disease. Immunol Today 1993; 14: 506–12.
- Hsu MM, Ko JY, Chang YL. Elevated levels of soluble interleukin-2 receptor, and tumor necrosis factor in nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1991; 117: 1257–9.
- Kuo WR, Yu HS, Chang KL, Juan KH, Jan YS, Yu CL. Increased production of tumor necrosis factor and release of soluble CD4 and CD8 molecules, but de-creased responsiveness to phytohemagglutinin in pa-tients with nasopharyngeal carcinoma. J Formosan Med Assoc 1994; 93: 569–75.
- Becker JC, Dummer R, Hartmann AA, Berg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFNy and tumor necro-sis factor a: Functional consequences on cell-mediated cytotoxicity. J Immunol 1991; 147: 4398–401.
- Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated en-dothelial cells. Biochem Biophys Res Commun 1992; 187: 584–9.
- Lowe D, Jorizzo J, Hutt MSR. Tumor-associated eosinophilia: a review. J Clin Pathol 1981; 84: 1343–8.
- Leighton SEJ, Teo JGC, Leung SF, Cheung AYK, Lee JCK, Andrew van Hasselt C. Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma. Cancer 1996; 77: 436–40.
- Gustafson RO, Neel HB III. Cancer immunology. In: Ballenger JJ, Snow Jr, JB, eds. Otolaryngology, head and neck surgery, 15th edn. Baltimore, MD: A Wa-verly Company, 1996: 671–7.
- Hsu MM, Lin BL. Characterization of T cell subsets using monoclonal antibodies in nasopharyngeal car-cinoma patients. Ann Otol Rhinol Laryngol 1986; 95: 298 —301.
- Hsu MM, Hsu HC, Lui LT. Local immune reaction in nasopharyngeal carcinoma, with special reference to its prognostic evaluation. Head Neck 1989; 11: 505–10.
- Wasserman SI, Goetz EJ, Ellman L, Austin KF. Tu-mor-associated eosinophilotactic factor. N Engl J Med 1974; 290: 420–4.